"We believe the COVID-19 screening tool is the next step in providing potentially new solutions for consumers aimed at combating this disease. We look forward to further refining this algorithm and working with regulators around the world to bring this important product to consumers as soon as possible."
The Resapp team is confident that the Pfizer acquisition will lead to accelerated research on the technology and that it will ultimately benefit remote parts of the world. At least, that was once the motivation behind the app's development.
what an irony, all this without a collaboration, but in our best interest ;-)
LOL
IMO
RAP Price at posting:
20.5¢ Sentiment: Sell Disclosure: Held
